Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome.

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works

Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition

Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982 · see citing works

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033 · see citing works

C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women

Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292 · see citing works

New Criteria for `Obesity Disease' in Japan

The Examination Committee of Criter (2002) · Circulation Journal · doi:10.1253/circj.66.987 · Cited by 1,650 · see citing works

Clinical Management of Metabolic Syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management

Grundy, S. M., Hansen, B., Smith, S. C., Cleeman, J. I., Kahn, R. A., & Participants, F. C. (2004) · Circulation · doi:10.1161/01.cir.0000112379.88385.67 · Cited by 864 · see citing works

Association of the Metabolic Syndrome With History of Myocardial Infarction and Stroke in the Third National Health and Nutrition Examination Survey

Ninomiya, J. K., L'Italien, G. J., Criqui, M. H., Whyte, J. L., Gamst, A. C., & Chen, R. S. (2003) · Circulation · doi:10.1161/01.cir.0000108926.04022.0c · Cited by 793 · see citing works

New Criteria for `Obesity Disease' in Japan

Oda, E. (2006) · Circulation Journal · doi:10.1253/circj.70.150 · Cited by 783 · see citing works

Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity

Guerre-Millo, M., Gervois, P., Raspé, E., Madsen, L., Poulain, P., Derudas, B., Herbert, J.-M., Winegar, D. A., Willson, T. M., Fruchart, J.-C., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.22.16638 · Cited by 605 · see citing works

The Metabolic Syndrome

Reilly, M. P., & Rader, D. J. (2003) · Circulation · doi:10.1161/01.cir.0000088846.10655.e0 · Cited by 466 · see citing works

Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels

Nakajima, K., SAITO, T., Tamura, A., Suzuki, M., Nakano, T., Adachi, M., Tanaka, A., Tada, N., Nakamura, H., Campos, E. M., et al. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90062-9 · Cited by 417 · see citing works

Role of Cytokines in Inducing Hyperlipidemia

Feingold, K. R., & Grünfeld, C. (1992) · Diabetes · doi:10.2337/diab.41.2.s97 · Cited by 380 · see citing works

Endothelial Dysfunction: Cause of the Insulin Resistance Syndrome

Pinkney, J. H., Stehouwer, C. D. A., Coppack, S. W., & Yudkin, J. S. (1997) · Diabetes · doi:10.2337/diab.46.2.s9 · Cited by 350 · see citing works

Remnant Lipoprotein Levels in Fasting Serum Predict Coronary Events in Patients With Coronary Artery Disease

Kugiyama, K., Doi, H., Takazoe, K., Kawano, H., Soejima, H., Mizuno, Y., Tsunoda, R., Sakamoto, T., Nakano, T., Nakajima, K., et al. (1999) · Circulation · doi:10.1161/01.cir.99.22.2858 · Cited by 284 · see citing works

Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia.

Greenberg, A. S., Nordan, R. P., McIntosh, J. K., Calvo, J. C., Scow, R. O., & Jablons, D. M. (1992) · PubMed · Cited by 277 · see citing works

Remnant Lipoproteins Induce Proatherothrombogenic Molecules in Endothelial Cells Through a Redox-Sensitive Mechanism

Doi, H., Kugiyama, K., Oka, H., Sugiyama, S., Ogata, N., Koide, S.-I., Nakamura, S.-I., & Yasue, H. (2000) · Circulation · doi:10.1161/01.cir.102.6.670 · Cited by 227 · see citing works

Association of Remnant Lipoprotein Levels With Impairment of Endothelium-Dependent Vasomotor Function in Human Coronary Arteries

Kugiyama, K., Doi, H., Motoyama, T., Soejima, H., Misumi, K., Kawano, H., Nakagawa, O., Yoshimura, M., Ogawa, H., Matsumura, T., et al. (1998) · Circulation · doi:10.1161/01.cir.97.25.2519 · Cited by 187 · see citing works

Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients

Paolisso, G., Barbagallo, M., Petrella, G., Ragno, E., Barbieri, M., Giordano, M., & Varricchio, M. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00352-4 · Cited by 171 · see citing works

Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina

Motoyama, T., Kawano, H., Kugiyama, K., Hirashima, O., Ohgushi, M., Tsunoda, R., Moriyama, Y., Miyao, Y., Yoshimura, M., Ogawa, H., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00447-1 · Cited by 170 · see citing works

Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial

Jonkers, I. J. A. M., Mohrschladt, M. F., Westendorp, R. G. J., van der Laarse, A., & Smelt, A. H. M. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01123-8 · Cited by 166 · see citing works

Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial — FAT)

Malík, J. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00382-0 · Cited by 149 · see citing works

Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation

Doi, H., Kugiyama, K., Ohgushi, M., Sugiyama, S., Matsumura, T., Ohta, Y., Nakano, T., Nakajima, K., & Yasue, H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00291-8 · Cited by 121 · see citing works

Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus

Fukushima, H., Sugiyama, S., Honda, O., Koide, S., Nakamura, S., Sakamoto, T., Yoshimura, M., Ogawa, H., Fujioka, D., & Kugiyama, K. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.09.074 · Cited by 91 · see citing works

The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk.

Ginsberg, H. N., & Stalenhoef, A. F. H. (2003) · PubMed · doi:10.1097/01.hjr.0000060840.46106.ea · Cited by 77 · see citing works

Mechanisms of endothelial dysfunction in the metabolic syndrome

DEEDWANIA, P. C. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0019-8 · Cited by 73 · see citing works

Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels

Kugiyama, K., Motoyama, T., Doi, H., Kawano, H., Hirai, N., Soejima, H., Miyao, Y., Takazoe, K., Moriyama, Y., Mizuno, Y., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00057-1 · Cited by 70 · see citing works

Aggregation of Human Blood Platelets by Remnant Like Lipoprotein Particles of Plasma Chylomicrons and Very Low Density Lipoproteins

Saniabadi, A. R., Umemura, K., Shimoyama, M., Adachi, M., Nakano, M., & Nakashima, M. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656092 · Cited by 62 · see citing works

Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease

Fukushima, H., Kugiyama, K., Sugiyama, S., Honda, O., Koide, S.-I., Nakamura, S.-I., Kawano, H., Soejima, H., Miyamoto, S., Yoshimura, M., et al. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02115-4 · Cited by 44 · see citing works

The Metabolic Syndrome: Targeting Dyslipidaemia to Reduce Coronary Risk

Ginsberg, H. N., & Stalenhoef, A. F. H. (2003) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670301000207 · Cited by 27 · see citing works

Lipid abnormalities in the metabolic syndrome

Brinton, E. A. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0056-3 · Cited by 22 · see citing works

Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease

Varbo, A., Benn, M., Tybjærg-Hansen, A., Jørgensen, A. B., Frikke-Schmidt, R., & Nordestgaard, B. G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1026 · Cited by 1,115 · see citing works

Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline

Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887 · see citing works

Remnant cholesterol as a cause of ischemic heart disease: Evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment

Varbo, A., Benn, M., & Nordestgaard, B. G. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.008 · Cited by 251 · see citing works

Triglycerides as vascular risk factors: new epidemiologic insights.

Kannel, W. B., & Vasan, R. S. (2009) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32832c1284 · Cited by 149 · see citing works

Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small, dense LDL.

Stalenhoef, A. F., & de Graaf, J. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328304b63c · Cited by 121 · see citing works

Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals

Nakamura, T., Obata, J.-E., Hirano, M., Kitta, Y., Fujioka, D., Saito, Y., Kawabata, K.-I., Watanabe, K., Watanabe, Y., Mishina, H., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.040 · Cited by 83 · see citing works

Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies

Ballantyne, C. M., Bays, H. E., Philip, S., Doyle, R. T., Braeckman, R. A., Stirtan, W. G., Soni, P. N., & Juliano, R. A. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.005 · Cited by 52 · see citing works

High Remnant Lipoprotein Predicts Recurrent Cardiovascular Events on Statin Treatment After Acute Coronary Syndrome

Nguyen, S. V., Nakamura, T., & Kugiyama, K. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0380 · Cited by 34 · see citing works

Effect of a Single 20-mg Tablet of Atorvastatin on Brachial Artery Blood Flow in Normolipidemic Male Smokers Versus Nonsmokers

Iida, K., Goland, S., Akima, T., et al. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.04.021 · Cited by 14 · see citing works

Effect of atorvastatin on hypercholesterolemia and endothelium-dependent vasodilatation

Yang, L. (2005) · Zhongguo kangfu lilun yu shijian

Effects of Atorvastatin discontinuation on vascular endothelial function in health young men

Zhang, Y. (2009) · Zhongguo xiandai yixue/Zhongguo xiandai yixue zazhi

[Comparative assessment of the results of ultrasonic measurements of postocclusive alterations in the brachial and cavernous arteries].

Mazo, E. B., Gamidov, S. I., Овчинников, Р. И., et al. (2007) · PubMed · Cited by 2 · see citing works

Pivotal role of inflammation in vascular endothelial dysfunction of hyperlipidemic rabbit and effects by atorvastatin

Chen, Y. X., Wang, X., Fu, Y., Yao, Y. J., Kong, M. Y., Nie, R., & Wang, J. F. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.06.019 · Cited by 22 · see citing works